YELLOX

This brand name is authorized in Austria, Croatia, Cyprus, Estonia, Finland, France, Ireland, Italy, Lithuania, Netherlands, Poland, Romania, Spain, UK.

Active ingredients

The drug YELLOX contains one active pharmaceutical ingredient (API):

1	Bromfenac UNII 8ECV571Y37 - BROMFENAC SODIUM
	Bromfenac is a topical, nonsteroidal anti-inflammatory drug (NSAID) for ophthalmic use. It is indicated for the treatment of postoperative inflammation and reduction of ocular pain in patients who have undergone cataract surgery. The mechanism of its action is thought to be due to its ability to block prostaglandin synthesis by inhibiting cyclooxygenase 1 and 2. The most commonly reported adverse reactions in 3 to 8% of patients were anterior chamber inflammation, foreign body sensation, eye pain, photophobia and vision blurred.
	Read more about Bromfenac

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
YELLOX Eye drops, solution	MPI, EU: SmPC	European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
S01BC11		S Sensory organs → S01 Ophthalmologicals → S01B Antiinflammatory agents → S01BC Antiinflammatory agents, non-steroids
Discover more medicines within S01BC11

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EE	Ravimiamet	1531459
ES	Centro de información online de medicamentos de la AEMPS	11692001, 11692001IP, 11692001IP1, 11692001IP2, 11692001IP4, 16692001IP3
FI	Lääkealan turvallisuus- ja kehittämiskeskus	147802
FR	Base de données publique des médicaments	64304674
GB	Medicines & Healthcare Products Regulatory Agency	191967, 375388, 381767
IT	Agenzia del Farmaco	041273018, 044954016, 044997017, 045423011, 045751017, 045839014, 046120010, 046769016, 047766011, 049739016, 050929013
LT	Valstybinė vaistų kontrolės tarnyba	1060677
NL	Z-Index G-Standaard, PRK	97985
PL	Rejestru Produktów Leczniczych	100247074
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W68463001